Australian researchers have called for improved notification of genetic testing for myeloproliferative neoplasms (MPNs) into population-based cancer registries. The call follows identification of changes in the incidence of polycythaemia vera (PV) and essential thrombocythaemia (ET) between 2003 and 2014, As reported in the American Journal of Hematology, 8,604 Australians were diagnosed with one of the ...
More data required on Australian rates of myeloproliferative neoplasms
By Mardi Chapman
29 Jan 2019